3 drug(s) with this reaction
46 total reports
Burn Oral Cavity has been reported as an adverse reaction across 3 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 46 adverse event reports mention burn oral cavity in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with burn oral cavity, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have burn oral cavity listed in their FDA adverse event reports, sorted by report count:
In addition to burn oral cavity, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
3 drug(s) manufactured by Haleon Us Holdings Llc have burn oral cavity listed in their FDA adverse event reports: STANNOUS FLUORIDE, POTASSIUM NITRATE AND SODIUM FLUORIDE, POTASSIUM NITRATE, SODIUM FLUORIDE.
There are a combined 46 reports of burn oral cavity across 3 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.